Cell and gene therapies, while still affecting a small number of patients, can carry per-treatment costs exceeding $500,000, creating catastrophic claims risk that disproportionately impacts smaller employer groups with less capacity to absorb outlier costs
Haase CL, Serratore Achenbach MG, Lucrezi G, Jeswani N, Maurer S, Egermann U
Los efectos secundarios ms comunes, generalmente leves y relacionados con dosis altas, incluyen nuseas, vmitos, calambres abdominales, diarrea y un olor corporal a pescado (trimethylaminuria)
Reduced physical activity often accompanies the initial weeks of GLP-1 therapy when gastrointestinal symptoms are most prominent
Problematischer sieht sie den Einsatz bei Menschen, die keine entsprechende Indikation haben und GLP-1-Prparate als Lifestyle-Medikament verwenden
Molecular Neurobiology